Voltar
Revisão Revisado por pares
BIBTEX RIS

Tumor antigens recognized by cytolytic T lymphocytes: Present perspectives for specific immunotherapy

1993; Wiley; Volume: 54; Issue: 2 Linguagem: Inglês

10.1002/ijc.2910540202

ISSN

1097-0215

Autores

Thierry Boon,

Tópico(s)

T-cell and B-cell Immunology

Resumo

International Journal of CancerVolume 54, Issue 2 p. 177-180 Human Cancer Tumor antigens recognized by cytolytic T lymphocytes: Present perspectives for specific immunotherapy† Thierry Boon, Corresponding Author Thierry Boon Ludwig Institute for Cancer Research, Brussels Branch, 74 avenue Hippocrate, B-1200 BrusselsCellular Genetics Unit, Université Catholique de Louvain B-1200 Brussels, Belgium. Fax: 02–762 94 05Search for more papers by this author Thierry Boon, Corresponding Author Thierry Boon Ludwig Institute for Cancer Research, Brussels Branch, 74 avenue Hippocrate, B-1200 BrusselsCellular Genetics Unit, Université Catholique de Louvain B-1200 Brussels, Belgium. Fax: 02–762 94 05Search for more papers by this author First published: 8 May 1993 https://doi.org/10.1002/ijc.2910540202Citations: 87 † Based on the author's Steiner Prize Award Lecture, with updating. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Aichele, P., Hengartner, H., Zinkernagel, R. M. and Schulz, M., Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J. exp. Med., 171, 1815–1820 (1990). 10.1084/jem.171.5.1815 CASPubMedWeb of Science®Google Scholar Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L. and Wiley, D. C., The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature (Lond.) 329 512–518 (1987). 10.1038/329512a0 CASPubMedWeb of Science®Google Scholar Boon, T. and Kellermann, O., Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line. Proc. nat. Acad. Sci. (Wash.), 74, 272–275 (1977). 10.1073/pnas.74.1.272 CASPubMedWeb of Science®Google Scholar Boon, T. and van Pel, A., Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line. Proc. nat. Acad. Sci. (Wash.), 75, 1519–1523 (1978). 10.1073/pnas.75.3.1519 CASPubMedWeb of Science®Google Scholar Brasseur, F., Marchand, M., Vanwijck, R., Hérin, M., Lethé, B., Chomez, P. and Boon, T., Human gene MAGE-1, which codes for a tumor rejection antigen, is expressed by some breast tumors. Int. J. Cancer, 52, 839–841 (1992). 10.1002/ijc.2910520528 CASPubMedWeb of Science®Google Scholar Cepko, C., Roberts, B. E. and Mulligan, R. C., Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell, 37, 1053–1062 (1984). 10.1016/0092-8674(84)90440-9 CASPubMedWeb of Science®Google Scholar Coulie, P. G., Somville, M., Lehmann, F., Hainaut, P., Brasseur, F., Devos, R. and Boon, T., Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells. Int. J. Cancer, 50, 289–297 (1992). 10.1002/ijc.2910500220 PubMedWeb of Science®Google Scholar dePlaen, E., Lurquin, C., van Pel, A., Mariamé, B., Szikora, J., Wölfel, T., Sibille, C., Chomez, P. and Boon, T., Tum- variants of mouse mastocytoma P815. IX. Cloning of the gene of tum - antigen P91A and identification of the tum- mutation. Proc. nat. Acad. Sci. (Wash.), 85, 2274–2278 (1988). 10.1073/pnas.85.7.2274 CASPubMedWeb of Science®Google Scholar Fearon, E. R. Pardoll, D. M., Itaya, T., Golumbek, P., Levitzky, H. I., Simons, J. W., Karasuyama, H., Vogelstein, B. and Frost, P., Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell, 60, 397–403 (1990). 10.1016/0092-8674(90)90591-2 CASPubMedWeb of Science®Google Scholar Foley, E. J., Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res., 13, 835–837 (1953). CASPubMedWeb of Science®Google Scholar Golumbek, P. T., Lazenby, A. J., Levitsky, H. I., Jaffee, L. M., Karasuyama, H., Baker, M. and Pardoll, D. M., Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science, 254, 713–716 (1991). 10.1126/science.1948050 CASPubMedWeb of Science®Google Scholar Jung, S. and Schluesner, H. J., Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins. J. exp. Med., 173, 273–276 (1991). 10.1084/jem.173.1.273 CASPubMedWeb of Science®Google Scholar Kast, W. M., Roux, L., Curren, J., Blom, H. J. J., Voordouw, A. C., Meloen, R. H., Kolakofsky, D. and Melief, C. J. M., Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. nat. Acad. Sci. (Wash.), 88, 2283–2287 (1991). 10.1073/pnas.88.6.2283 CASPubMedWeb of Science®Google Scholar Lopez-Nevot. M. A., Esteban, F., Ferron, A., Gutierrez, J., Oliva, M. R., Romero, C., Huelin, C., Ruiz-Cabello, F. and Garrido, F., HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas. Brit. J. Cancer, 59, 221–226 (1989). 10.1038/bjc.1989.45 PubMedWeb of Science®Google Scholar Lurquin, C., van Pel, A., Mariamé, B., de Plaen, E., Szikora, J., Janssens, C., Reddehase, M., Lejeune, J. and Boon, T., Structure of the gene coding for tum- transplantation antigen P91A. A peptide encoded by the mutated exon is recognized with Ld by cytolytic T cells. Cell, 58, 293–303 (1989). 10.1016/0092-8674(89)90844-1 CASPubMedWeb of Science®Google Scholar Peace, D. J., Chen, W., Nelson, H. and Cheever, M. A., T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes. J. Immunol., 146, 2059–2065 (1991). CASPubMedWeb of Science®Google Scholar Prehn, R. T. and Main, J. M., Immunity to methylcholanthrene-induced sarcomas. J. nat. Cancer Inst., 18, 769–778 (1957). CASPubMedWeb of Science®Google Scholar Raychaudhuri, S., Tonks, M., Carbone, F., Ryskamp, T., Morrow, W. J. W. and Hanna, N., Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo. Proc. nat. Acad. Sci. (Wash.), 89, 8308–8312 (1992). 10.1073/pnas.89.17.8308 CASPubMedWeb of Science®Google Scholar Sibille, C., Chomez, P., Wildmann, C., van Pel, A., de Plaen, E., Maryanski, J., de Bergeyck, V. and Boon, T., Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide. J. exp. Med., 172, 35–45 (1990). 10.1084/jem.172.1.35 CASPubMedWeb of Science®Google Scholar Stover, C. K., de la Cruz, V. F., Fuerst, T. R., Burlein, J. E., Benson, L. A., Bennett, L. T., Bansal, G. P., Young, J. F., Lee, M. H., Hatfull, G. F., Snapper, S. B., Barleita, R. G., Jacobs, W. R., Jr. and Bloom, B. R., New use of BCG for recombinant vaccines. Nature (Lond.), 351, 456–461 (1991). 10.1038/351456a0 Google Scholar Szikora, J., van Pel, A., Brichard, V., André, M., van Baren, N., Henry, P., de Plaen, E. and Boon, T., Structure of the gene of tum- transplantation antigen P35B: presence of a point mutation in the antigenic allele. EMBOJ., 9, 1041–1050 (1990): 10.1002/j.1460-2075.1990.tb08208.x CASPubMedWeb of Science®Google Scholar Taylor, J., Weinberg, R., Tartaglia, J., Richardson, C., Alkhatib, G., Briedis, D., Appel, M., Norton, E. and Paoletti, E., Non-replicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology, 187, 321–328 (1992). 10.1016/0042-6822(92)90321-F CASPubMedWeb of Science®Google Scholar Townsend, A., Rothbard, J., Gotch, F., Bahadur, G., Wraith, D. and McMichael, A., The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell, 44, 959–968 (1986). 10.1016/0092-8674(86)90019-X CASPubMedWeb of Science®Google Scholar Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., van Pel, A., de Plaen, E., Amar-Costesec, A. and Boon, T., A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by CTL directed against tumor antigen MZ2-E. J. exp. Med., 176, 1453–1457 (1992a). 10.1084/jem.176.5.1453 CASPubMedWeb of Science®Google Scholar Traversari, C., van der Bruggen, P., van den Eynde, B., Hainaut, P., Lemoine, C., Ohta, N., Old, L. and Boon, T., Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics, 35, 145–152 (1992b). 10.1007/BF00185107 CASPubMedWeb of Science®Google Scholar Van den Eynde, B., Lethé, B., van Pel, A., de Plaen, E. and Boon, T., The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. exp. Med., 173, 1373–1384 (1991). 10.1084/jem.173.6.1373 CASPubMedWeb of Science®Google Scholar van der Bruggen, P., Traversari, C., Chomez, P., Lurouin, C., dePlaen, E., van den Eynde, B., Knuth, A. and Boon, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643–1647 (1991). 10.1126/science.1840703 CASPubMedWeb of Science®Google Scholar Weiss, A., Brunner, K., McDonald, R. and Cerottini, J. C., Antigenic specificity of the cytolytic T lymphocyte response to murine sarcoma virus-induced tumors. III. Characterization of cytolytic T lymphocyte clones specificity for Moloney leukemia. J. exp. Med., 152, 1210–1225 (1980). 10.1084/jem.152.5.1210 CASPubMedWeb of Science®Google Scholar Weynants, P., Wauters, P., Coulie, P. G., van den Eynde, B., Symann, M. and Boon, T., Cytolytic response of human T cells against allogeneic small cell lung carcinoma treated with interferon gamma. Cancer Immunol. Immunother., 27, 228–232 (1988). 10.1007/BF00205444 CASPubMedWeb of Science®Google Scholar Zheng, B., Brett, S. J., Tite, J. P., Lifely, M. R., Brodie, T. A. and Rhodes, J., Galactose oxidation in the design of immunogenic vaccines. Science, 256, 1560–1563 (1992). 10.1126/science.1598588 CASPubMedWeb of Science®Google Scholar Citing Literature Volume54, Issue28 May 1993Pages 177-180 ReferencesRelatedInformation

Referência(s)